BioSpace News Archive

Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, announced that the Company’s Chief Science Officer and Co-Founder, Marty Emanuele, Ph.D., will present at the 4th Annual Dry AMD Therapeutic Development Summit on November 16th in Boston, Massachusetts.

Viseon Inc. announces the company’s first use of the MaxView® 4K Advanced Digital Visualization system during a neurosurgical tumor resection procedure.

Repairon together with the University Medical Center Göttingen and Lübeck as well as the German Center for Cardiovascular Research, announced that its Co-Founder Professor Wolfram Zimmermann held a Featured Science presentation at the American Heart Association Scientific Sessions 2023 on November 12, 2023, in Philadelphia, US.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, announced topline results from its Phase 2a, randomized, placebo-controlled, proof-of-concept trial of LYT-300.

Ergomed plc and Permira Advisers LLP, are pleased to announce the completion of the acquisition of Ergomed by funds advised by Permira for £703.1 million.

Oxford Nanopore and Day Zero Diagnostics announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.

Biodesix, Inc. announced the validation and launch of a new method of collecting blood specimens for Nodify Lung Nodule Risk Assessment testing.

Study with leading physician-scientists will provide unprecedented insights into the underlying biology of pregnancy to identify those most at risk for adverse pregnancy complications that affect 1 in 5 pregnancies

HCW Biologics Inc. today reported financial results and recent business highlights for its third quarter ended September 30, 2023.

Trevena, Inc. reported its financial results for the third quarter ended September 30, 2023 and provided an overview of its recent operational highlights.